Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Tuberculosis

Free Subscription Articles published in Lancet Retrieve available abstracts of 86 articles: HTML format

Single Articles

April 2021
1. WALTER KS, Martinez L, Arakaki-Sanchez D, Sequera VG, et al
   The escalating tuberculosis crisis in central and South American prisons.
   Lancet. 2021 Apr 8. pii: S0140-6736(20)32578.
   PubMed     Abstract available
   
   
   March 2021
2. NKEREUWEM E, Kampmann B, Togun T
   The need to prioritise childhood tuberculosis case detection.
   Lancet. 2021 Mar 22. pii: S0140-6736(21)00672.
   PubMed    
   
   
   
3. LANE R
   Nicole Salazar-Austin: emerging tuberculosis-HIV research leader.
   Lancet. 2021 Mar 18. pii: S0140-6736(21)00587.
   PubMed    
   
   
   January 2021
4. MACLEAN E, Bigio J, Singh U, Klinton JS, et al
   Global tuberculosis awards must do better with equity, diversity, and inclusion.
   Lancet. 2021;397:192-193.
   PubMed    
   
   
   September 2020
5. BURKI T
   Inappropriate behaviour claims at Stop TB prompt review.
   Lancet. 2020;396:876.
   PubMed    
   
   
   August 2020
6. BISSON GP, Bastos M, Campbell JR, Bang D, et al
   Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis.
   Lancet. 2020;396:402-411.
   PubMed     Abstract available
   
   
   
7. MAYANJA-KIZZA H, Sekaggya-Wiltshire C, Kassa D
   Optimal therapy for multidrug-resistant tuberculosis and HIV.
   Lancet. 2020;396:363-365.
   PubMed    
   
   
   April 2020
8. 
   Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.
   Lancet. 2020 Apr 23. pii: S0140-6736(20)30608.
   PubMed     Abstract available
   
   
   
9. SUNDEWALL J, Forsberg BC
   Understanding health spending for SDG 3.
   Lancet. 2020 Apr 23. pii: S0140-6736(20)30963.
   PubMed    
   
   
   March 2020
10. MARTINEZ L, Cords O, Horsburgh CR, Andrews JR, et al
    The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis.
    Lancet. 2020;395:973-984.
    PubMed     Abstract available
    
    
    
11. SAHU S, Ditiu L, Lawson L, Ntoumi F, et al
    UN General Assembly tuberculosis targets: are we on track?
    Lancet. 2020;395:928-930.
    PubMed    
    
    
    
12. CAMPBELL JR, Bastos ML
    No time to waste: preventing tuberculosis in children.
    Lancet. 2020;395:924-926.
    PubMed    
    
    
    
13. LANE R
    Sean Wasserman: rising star in TB-HIV research and medicine.
    Lancet. 2020;395:941.
    PubMed    
    
    
    
14. KIM HY, Heysell SK, Mpagama S, Marais BJ, et al
    Challenging the management of drug-resistant tuberculosis.
    Lancet. 2020;395:783.
    PubMed    
    
    
    
15. LANGE C, Dheda K, Chesov D, Mandalakas AM, et al
    Challenging the management of drug-resistant tuberculosis - Authors' reply.
    Lancet. 2020;395:783-784.
    PubMed    
    
    
    
16. GASKELL KM, Moore DAJ
    Challenging the management of drug-resistant tuberculosis.
    Lancet. 2020;395:782-783.
    PubMed    
    
    
    February 2020
17. LANE R
    Hans Kluge: charismatic, new WHO Regional Director for Europe.
    Lancet. 2020;395:329.
    PubMed    
    
    
    November 2019
18. VARO R, Bila R, Saavedra B, Sitoe A, et al
    Paraplegia and spinal deformity in a Mozambican child with Pott's disease and tuberculous scrofula.
    Lancet. 2019;394:1651.
    PubMed    
    
    
    October 2019
19. THE LANCET
    End the tuberculosis emergency: a promise is not enough.
    Lancet. 2019;394:1482.
    PubMed    
    
    
    
20. RAY S, Anand K
    Reduce the delay in tuberculosis diagnosis in India.
    Lancet. 2019 Oct 24. pii: S0140-6736(19)32476.
    PubMed    
    
    
    
21. TCHIOMBIANO S, Delfraissy JF, Dabis F
    The Global Fund's Sixth Replenishment Conference: a challenge for France, a challenge for global health.
    Lancet. 2019;394:1214-1215.
    PubMed    
    
    
    September 2019
22. REUTER A, Hughes J, Furin J
    Challenges and controversies in childhood tuberculosis.
    Lancet. 2019;394:967-978.
    PubMed     Abstract available
    
    
    
23. LANGE C, Dheda K, Chesov D, Mandalakas AM, et al
    Management of drug-resistant tuberculosis.
    Lancet. 2019;394:953-966.
    PubMed     Abstract available
    
    
    
24. THE LANCET
    Tuberculosis needs accelerated and continued attention.
    Lancet. 2019;394:896.
    PubMed    
    
    
    August 2019
25. REID MJA, Goosby E
    A tuberculosis-free world: is it a delusion? - Authors' reply.
    Lancet. 2019 Aug 12. pii: S0140-6736(19)31411.
    PubMed    
    
    
    
26. ATRE S
    A tuberculosis-free world: is it a delusion?
    Lancet. 2019 Aug 12. pii: S0140-6736(19)31623.
    PubMed    
    
    
    July 2019
27. BASHAM CA, Elias B, Orr P
    Tuberculosis elimination in Canada.
    Lancet. 2019;394:300-301.
    PubMed    
    
    
    
28. MENZIES D, Benedetti A, Migliori GB, Nahid P, et al
    Multidrug-resistant tuberculosis - Authors' reply.
    Lancet. 2019;394:299-300.
    PubMed    
    
    
    
29. CHIANG CY, Van Deun A, Trebucq A, Piubello A, et al
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:299.
    PubMed    
    
    
    
30. CAMINERO JA, Garcia-Basteiro AL, Rendon A
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:298.
    PubMed    
    
    
    
31. NYANG'WA BT, Berry C, Fielding K, Nunn AJ, et al
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:298-299.
    PubMed    
    
    
    May 2019
32. FRIEBEL R, Silverman R, Glassman A, Chalkidou K, et al
    On results reporting and evidentiary standards: spotlight on the Global Fund.
    Lancet. 2019;393:2006-2008.
    PubMed    
    
    
    March 2019
33. ZUCCALA E, Horton R
    Time to bring tuberculosis out of the shadows.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30486.
    PubMed    
    
    
    
34. KI-MOON B
    Building a tuberculosis-free world on a foundation of universal health coverage.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30433.
    PubMed    
    
    
    
35. ZAROCOSTAS J
    Nandita Venkatesan: a voice of hope for tuberculosis survivors.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30582.
    PubMed    
    
    
    
36. NADDA JP
    India's leadership to end tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30487.
    PubMed    
    
    
    
37. KUMAR A
    Picturing health: it's time to act on tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30583.
    PubMed    
    
    
    
38. WEBSTER P
    Inuit research raises concerns about tuberculosis eradication.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30681.
    PubMed    
    
    
    
39. REID MJA, Arinaminpathy N, Bloom A, Bloom BR, et al
    Building a tuberculosis-free world: The Lancet Commission on tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30024.
    PubMed    
    
    
    
40. FURIN J, Cox H, Pai M
    Tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30308.
    PubMed     Abstract available
    
    
    
41. WATTS G
    Christine Sekaggya-Wiltshire: prizewinner in HIV-tuberculosis research.
    Lancet. 2019 Mar 19. pii: S0140-6736(19)30644.
    PubMed    
    
    
    
42. PAGE KR, Doocy S, Reyna Ganteaume F, Castro JS, et al
    Venezuela's public health crisis: a regional emergency.
    Lancet. 2019 Mar 11. pii: S0140-6736(19)30344.
    PubMed     Abstract available
    
    
    February 2019
43. STORY A, Aldridge RW, Smith CM, Garber E, et al
    Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.
    Lancet. 2019 Feb 21. pii: S0140-6736(18)32993.
    PubMed     Abstract available
    
    
    
44. FRASER H, Keshavjee S
    Video-observed therapy for tuberculosis: strengthening care.
    Lancet. 2019 Feb 21. pii: S0140-6736(19)30293.
    PubMed    
    
    
    January 2019
45. FERRY G
    Dorothy Stopford Price and the control of tuberculosis in Ireland.
    Lancet. 2019;393:20.
    PubMed    
    
    
    November 2018
46. GRANICH R
    Is the global tuberculosis control strategy too big to fail?
    Lancet. 2018 Nov 1. pii: S0140-6736(18)32751.
    PubMed    
    
    
    October 2018
47. COUSINS S
    UN High-Level meeting to end tuberculosis disappointing.
    Lancet. 2018 Oct 3. pii: S0140-6736(18)32458.
    PubMed    
    
    
    September 2018
48. MARAIS B, Zumla A
    Advancing global tuberculosis control after the UNGA-HLM.
    Lancet. 2018 Sep 24. pii: S0140-6736(18)32361.
    PubMed    
    
    
    
49. AHMAD N, Ahuja SD, Akkerman OW, Alffenaar JC, et al
    Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    Lancet. 2018;392:821-834.
    PubMed     Abstract available
    
    
    
50. FARMER PE
    Better and safer treatment for multidrug-resistant tuberculosis.
    Lancet. 2018;392:798-800.
    PubMed    
    
    
    
51. REUTER A, Furin J
    Reducing harm in the treatment of multidrug-resistant tuberculosis.
    Lancet. 2018;392:797-798.
    PubMed    
    
    
    August 2018
52. GARBARINO MC, Cani V, Mazzarello P
    A century ago: Carlo Forlanini and the first successful treatment of tuberculosis.
    Lancet. 2018;392:475.
    PubMed    
    
    
    July 2018
53. GUPTA-WRIGHT A, Corbett EL, van Oosterhout JJ, Wilson D, et al
    Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31267.
    PubMed     Abstract available
    
    
    
54. NATHAVITHARANA RR, Pai M
    New strategies for inpatients with HIV and tuberculosis.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31442.
    PubMed    
    
    
    May 2018
55. CHATTOPADHYAY A, Sharma A, Gupta K, Jain S, et al
    The Phemister triad.
    Lancet. 2018;391:e20.
    PubMed    
    
    
    
56. COUSINS S
    Managing MDR tuberculosis in Nepal.
    Lancet. 2018;391:1760-1761.
    PubMed    
    
    
    April 2018
57. COSTELLO A
    The Global Fund links with Lombard Odier bank.
    Lancet. 2018;391:1674-1675.
    PubMed    
    
    
    March 2018
58. PARK KB, Khan U, Seung K
    Open letter to The Global Fund about its decision to end DPRK grants.
    Lancet. 2018;391:1257.
    PubMed    
    
    
    
59. SHARMA D
    Commitments to an end to tuberculosis renewed in India.
    Lancet. 2018;391:1138.
    PubMed    
    
    
    
60. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
    The Lancet Commission on tuberculosis: building a tuberculosis-free world.
    Lancet. 2018;391:1132-1133.
    PubMed    
    
    
    
61. WINGFIELD T, Tovar MA, Datta S, Saunders MJ, et al
    Addressing social determinants to end tuberculosis.
    Lancet. 2018;391:1129-1132.
    PubMed    
    
    
    
62. DAVIES R
    Leo Martinez: striving to end childhood tuberculosis.
    Lancet. 2018 Mar 21. pii: S0140-6736(18)30680.
    PubMed    
    
    
    
63. THE LANCET
    The Global Fund under Peter Sands.
    Lancet. 2018;391:912.
    PubMed    
    
    
    January 2018
64. THE LANCET
    Tuberculosis: criteria for global leadership?
    Lancet. 2018;391:2.
    PubMed    
    
    
    September 2017
65. POKROVSKY V
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    PubMed    
    
    
    
66. COX H, Reuter A, Furin J, Seddon J, et al
    Prevention of hearing loss in patients with multidrug-resistant tuberculosis.
    Lancet. 2017;390:934.
    PubMed    
    
    
    June 2017
67. VENKATESH P
    Tuberculosis in India: health policy alone is not enough.
    Lancet. 2017;389:2471.
    PubMed    
    
    
    
68. PAI M, Jha P
    Tuberculosis in India: health policy alone is not enough - Authors' reply.
    Lancet. 2017;389:2471-2472.
    PubMed    
    
    
    March 2017
69. SHARMA DC
    New plan to end tuberculosis in south and southeast Asia.
    Lancet. 2017;389:1183.
    PubMed    
    
    
    
70. ADAM BU, Cosford P, Anderson SR, Abubakar I, et al
    Sustaining tuberculosis decline in the UK.
    Lancet. 2017;389:1176-1177.
    PubMed    
    
    
    
71. PAI M, Correa N, Mistry N, Jha P, et al
    Reducing global tuberculosis deaths-time for India to step up.
    Lancet. 2017;389:1174-1176.
    PubMed    
    
    
    February 2017
72. SHARMA DC
    India plans to expand access to new tuberculosis drug.
    Lancet. 2017;389:685.
    PubMed    
    
    
    
73. COUSINS S
    Myanmar grapples with its high tuberculosis burden.
    Lancet. 2017;389:491-492.
    PubMed    
    
    
    January 2017
74. CLINTON C, Sridhar D
    Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Lancet. 2017 Jan 27. pii: S0140-6736(16)32402.
    PubMed     Abstract available
    
    
    November 2016
75. CARRUTH L, Roess AA, Mekonnen YT, Melaku SK, et al
    Zoonotic tuberculosis in Africa: challenges and ways forward.
    Lancet. 2016;388:2460-2461.
    PubMed    
    
    
    
76. BERRY C, Achar J, du Cros P
    WHO recommendations for multidrug-resistant tuberculosis.
    Lancet. 2016;388:2234.
    PubMed    
    
    
    
77. SOTGIU G, Tiberi S, D'Ambrosio L, Centis R, et al
    WHO recommendations for multidrug-resistant tuberculosis - Authors' reply.
    Lancet. 2016;388:2234-2235.
    PubMed    
    
    
    
78. ZAK D, Scriba TJ, Hatherill M, Penn-Nicholson A, et al
    Predicting tuberculosis risk - Authors' reply.
    Lancet. 2016;388:2233-2234.
    PubMed    
    
    
    
79. KIK SV, Cobelens F, Moore D
    Predicting tuberculosis risk.
    Lancet. 2016;388:2233.
    PubMed    
    
    
    October 2016
80. NADDA JP, Singh PK
    New evidence of the tuberculosis burden in Asia demands national action.
    Lancet. 2016 Oct 14. pii: S0140-6736(16)31853.
    PubMed    
    
    
    
81. ALDRIDGE RW, Zenner D, White PJ, Williamson EJ, et al
    Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland.
    Lancet. 2016 Oct 10. pii: S0140-6736(16)31008.
    PubMed     Abstract available
    
    
    
82. REINL J
    UN declaration on antimicrobial resistance lacks targets.
    Lancet. 2016;388:1365.
    PubMed    
    
    
    
83. CHEN S, Zhang H, Qu Y, Wu Y, et al
    Occupational challenges of physicians involved in tuberculosis control in China: a qualitative study.
    Lancet. 2016;388 Suppl 1:S88.
    PubMed     Abstract available
    
    
    
84. GAO L, Bai L, Liu J, Lu W, et al
    Identification of populations at high risk of tuberculosis infection in rural China: a population-based, multicentre, prospective study.
    Lancet. 2016;388 Suppl 1:S16.
    PubMed     Abstract available
    
    
    July 2016
85. FEDER HM JR, Rigos L, Teti K
    Pott's disease in a Connecticut toddler.
    Lancet. 2016;388:504.
    PubMed    
    
    
    
86. RUBENSTEIN LS, Amon JJ, McLemore M, Eba P, et al
    HIV, prisoners, and human rights.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30663.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: